Find Academic Supervisors

Han Cun is an Assistant Professor in the Department of Obstetrics and Gynecology-Gynecologic Oncology at the University of Chicago. His research primarily focuses on gynecologic malignancies, with specialized expertise in endometrial cancer, uterine leiomyosarcoma, and molecular characterization of tumors. His work bridges clinical oncology with molecular diagnostics to develop targeted therapeutic approaches. Dr. Cun's research investigates molecular pathways in gynecologic cancers, recurrence patterns, and novel treatment strategies. His publications demonstrate consistent focus on translational research with clinical applications in oncology, particularly through comprehensive molecular profiling and therapeutic target identification. His collaborative research network includes partnerships with Ayman Al-Hendy and Obianuju Madueke-Laveaux, with publications appearing in high-impact journals including Gynecologic Oncology , Cells , and Cancers . Research trends indicate strong focus on molecular characterization of endometrial cancers and therapeutic development for uterine malignancies.

• Gynecologic Oncology
• Endometrial Cancer
• Uterine Leiomyosarcoma
• +3 more

Garrett K Lam, MD is a Professor in the Department of Obstetrics and Gynecology at the University of Kentucky College of Medicine. His clinical and academic work focuses on obstetrics, gynecology, and women's health, with potential involvement in high-risk pregnancies and gynecologic subspecialties through the department's divisions. Contact: Garrett.Lam@uky.edu

• Obstetrics
• Gynecology
• Women's Health
• +3 more

Dr. Lloyd D Fisher is an Assistant Professor in the Department of Pediatrics at UMass Chan Medical School, with additional responsibilities in the Division of Community Pediatrics. He is professionally affiliated with Reliant Medical Group in Worcester, MA. His educational background includes a BS in Biology from the University of Vermont and an MD from the University of Massachusetts Medical School. Dr. Fisher's research focuses on public health interventions, vaccinology, and health equity, with particular expertise in: Designing and evaluating vaccination programs (influenza/COVID-19) Addressing health disparities in pediatric populations Implementing digital health solutions for preventive care Cardiovascular outcomes research His publication record demonstrates evolving research interests: early work (2002-2004) focused on cardiology and diagnostic methods, while recent publications (2016-2024) concentrate on vaccine delivery systems, pandemic response, and health technology interventions. This shift reflects a transition toward public health implementation science with emphasis on pragmatic clinical trials.

• Public Health
• Vaccinology
• Pediatrics
• +3 more

Dr. Rony Elias is an Associate Professor of Clinical Obstetrics and Gynecology and Clinical Reproductive Medicine at The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine (CRM) of Weill Cornell Medical College. He is also an Associate Attending Obstetrician/Gynecologist at NewYork-Presbyterian Hospital, specializing in reproductive medicine, IVF, and minimally invasive gynecologic surgery. Board certified in Obstetrics and Gynecology, and Reproductive Endocrinology and Infertility Clinical expertise includes IVF, IUI, endometriosis, robotic/laparoscopic surgery, and fertility preservation His research focuses on uterine factors affecting infertility, novel stimulation protocols for egg maturity, and fertility preservation for cancer patients. He has authored peer-reviewed articles and presented at national/international conferences. Berlex Award for contributions to medical education GWU Resident Award for consistent excellence during residency CREOG awards for high scores on national exams Dr. Elias emphasizes a holistic patient approach, fluent in English, French, and Arabic, with offices in Manhattan's Upper East Side and Westchester County.

• Reproductive Medicine
• Obstetrics and Gynecology
• Infertility
• +3 more

Dr. Hey-Joo Kang is a Clinical Associate Professor of Obstetrics and Gynecology and Clinical Reproductive Medicine at Weill Cornell Medical College. She practices at the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine (CRM), specializing in reproductive endocrinology and infertility. Education : SUNY at Buffalo School of Medicine, residency at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, fellowship at CRM. Clinical Expertise : Reproductive Medicine Female Infertility In Vitro Fertilization (IVF) Ovulation Induction Fertility Surgery Endometriosis Polycystic Ovarian Syndrome (PCOS) Gynecologic Surgery Assisted Reproductive Technology Research Focus : Embryo implantation and epigenetic factors affecting IVF outcomes. She has contributed to numerous articles and textbook chapters in reproductive endocrinology and infertility. Honors : Excellence in Teaching Award (chief resident) Fellow of the American College of Obstetricians and Gynecologists (ACOG) Member of the American Society for Reproductive Medicine (ASRM)

• Reproductive Medicine
• Female Infertility
• In Vitro Fertilization (IVF)
• +9 more

Dr. Samantha M. Pfeifer is an Associate Professor of Clinical Obstetrics and Gynecology and Clinical Reproductive Medicine at Weill Cornell Medical College. She specializes in reproductive medicine, fertility preservation (egg freezing), and reproductive surgery, including minimally invasive and robotic techniques. Her clinical focus encompasses endometriosis, Müllerian anomalies, and hormonal disorders in adolescent girls. Education: A.B. in Economics from Bryn Mawr College, Medical Degree, Obstetrics/Gynecology residency, and Reproductive Endocrinology fellowship at the University of Pennsylvania. Dr. Pfeifer leads the Practice Committee of the American Society for Reproductive Medicine and has contributed research on IVF, Müllerian anomalies, and adolescent hormonal disorders. She is a frequent speaker at medical conferences and has been recognized in regional/national best-physician lists, including Castle Connolly's Top Doctors. Awards: ACOG Mentor of the Year Award (2010). She sees patients at the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine in Tribeca, New York, and maintains affiliations with NewYork-Presbyterian Hospital.

• Reproductive Medicine
• In Vitro Fertilization (IVF)
• Fertility Preservation
• +4 more

Dr. Sangeeta Jain is a Professor in the Department of Obstetrics & Gynecology, specializing in Maternal Fetal Medicine at the University of Texas Medical Branch (UTMB) in Galveston, TX. She serves as the Medical Director of OB Ultrasound at the institution and is board certified in Obstetrics and Gynecology and subspecialty Maternal Fetal Medicine by the American Board of Obstetrics and Gynecology. Her clinical expertise focuses on Medical Complications in Pregnancy, Critical Care in Pregnancy, and Fetal ECHO. Dr. Jain's research program spans several critical areas in maternal-fetal medicine, with particular emphasis on preterm labor , fetal echocardiography , maternal obesity and nutrition in pregnancy , and simulation models in medical education . Dr. Jain's scholarly work demonstrates a commitment to understanding pregnancy complications and improving maternal-fetal outcomes through her publications addressing congenital disorders, acute pancreatitis in pregnancy, hypertensive disorders, maternal nutrition, and the impact of SARS-CoV-2 variants on pregnancy outcomes. Golden Apple Award recipient for medical student education As Principal Investigator, Dr. Jain leads two major research projects: a Phase 3 clinical trial evaluating Nipocalimab for pregnancies at risk for severe HDFN (2024-2029), and a historical cohort study characterizing management and outcomes of pregnancies with early onset severe HDFN (2023-2027). Her research fingerprint shows strong engagement with Pregnant Women (100%), Pregnancy (75%), Obstetrics and Gynaecology (60%), and related fields.

• Maternal Fetal Medicine
• Obstetrics and Gynecology
• Preterm labor
• +5 more

Dr. Gayle Koutrouvelis is a Professor in the Department of Obstetrics and Gynecology at the University of Texas Medical Branch (UTMB), holding the Hiram & Gloria Arnold Endowed Professorship for Teaching Excellence. She serves as Director of the Maternal Fetal Medicine Fellowship Program, Medical Director, and Vice Chair of Quality and Value, demonstrating her leadership in both clinical care and academic medicine. Dr. Koutrouvelis earned her medical degree from Creighton University School of Medicine in Omaha, NE, completed residency at Union Memorial Hospital in Baltimore, and pursued fellowship training in Maternal Fetal Medicine at the University of Maryland School of Medicine. Her professional journey includes induction into the Academy of Master Teachers in 2007 and recognition in Super Doctors® since 2013. Her research focuses on Diabetes and Obesity in pregnancy , with significant contributions to understanding gestational diabetes management, obesity-related complications, and metabolic conditions during pregnancy. Dr. Koutrouvelis has published extensively on pregnancy outcomes related to vascular complications and emerging health threats, including the impact of SARS-CoV-2 variants on pregnant women. Her work spans clinical trials, systematic reviews, and translational research aimed at improving maternal-fetal outcomes. Analysis of her 65 research outputs reveals a consistent pattern of scholarly activity with emphasis on metabolic disorders in pregnancy, evidenced by high citation counts for recent publications including the MOMPOD clinical trial in JAMA (2023) with 47 Scopus citations. Her research shows increasing impact in the last five years, with publications appearing in high-impact journals and receiving substantial media attention. Academy of Master Teachers (2007) Super Doctors® recognition (2013) As Director of the Maternal Fetal Medicine Fellowship, Dr. Koutrouvelis mentors future specialists in high-risk obstetrics while leading multiple funded research initiatives. Her current projects include the PK and Safety of Commonly Used Drugs in Lactating Women study (2023-2026) with Duke University and the Prematurity Risk Assessment project (PRIME, 2022-2027) with SERA Prognostics, Inc. She has successfully secured substantial research funding from national institutions to address critical gaps in maternal-fetal medicine. Dr. Koutrouvelis's research team collaborates across multiple institutions, focusing on evidence-based interventions for complex maternal conditions. Her work bridges clinical practice and research translation, with particular attention to optimizing care for women with diabetes and obesity during pregnancy. Her leadership extends to quality improvement initiatives within the department, ensuring high standards of patient care while advancing the scientific understanding of maternal-fetal conditions.

• Maternal Fetal Medicine
• Diabetes in Pregnancy
• Obesity Management
• +5 more

Dr. Chasey Ikuvbogie Omere is an Assistant Professor in the Department of Obstetrics & Gynecology at the University of Texas Medical Branch (UTMB) in Galveston, Texas. She is board certified in both Obstetrics and Gynecology and Maternal Fetal Medicine by the American Board of Obstetrics and Gynecology. Dr. Omere received her medical degree from the University of Texas Medical Branch School of Medicine and completed both her OBGYN residency and Maternal Fetal Medicine fellowship at UTMB in Galveston. She is a recipient of the Golden Apple Award for medical student education, highlighting her commitment to teaching. Her clinical interests focus on maternal disease, fetal growth abnormalities, and preterm labor. Her research spans critical areas including preterm labor, fetal growth abnormalities, hypertensive disease in pregnancy, and pharmacology in pregnancy. Analysis of her recent publications shows a strong emphasis on high-risk pregnancy complications, infectious disease impacts on pregnancy, and innovative monitoring techniques for prenatal care. Her scientific contributions include: Research on obstetric sepsis diagnostics and management Studies on acute kidney injury in critical obstetric care Investigations into fetal pulse oximetry technology Analysis of SARS-CoV-2 variants' impact on pregnancy outcomes Exploration of inflammatory pathways in pregnancy and parturition Dr. Omere currently serves as Principal Investigator for the Trans-abdominal fetal pulse oximetry: PILOT 1 project (2021-2026), funded by Raydiant Oximetry, Inc. Her work demonstrates a commitment to advancing maternal-fetal medicine through both clinical practice and research innovation.

• Maternal Fetal Medicine
• Obstetrics
• Gynecology
• +4 more

Erik Rytting, PhD, MS serves as Associate Professor in both the Department of Obstetrics & Gynecology and Department of Pharmacology & Toxicology at the University of Texas Medical Branch, while directing the Nanomedicine Laboratory. His dual appointments reflect the interdisciplinary nature of his work bridging clinical obstetrics and pharmaceutical sciences. His educational background includes a B.S. in Chemical Engineering from Brigham Young University and a Ph.D. in Pharmaceutical Chemistry from the University of Kansas, providing the foundation for his expertise in drug delivery systems. These qualifications positioned him to address critical challenges in maternal-fetal pharmacology. Dr. Rytting's research program focuses on developing improved drug delivery strategies with special emphasis on transplacental transport mechanisms. His work addresses urgent clinical needs for pregnant women requiring pharmacotherapy for conditions including asthma, diabetes, epilepsy, HIV, and cancer, while ensuring fetal safety. The laboratory actively investigates nanoparticle transport across the placenta using BeWo cell models and explores therapeutic applications for fetal arrhythmias and congenital disorders requiring precise drug targeting. Analysis of his recent publications reveals a strong trajectory in nanomedicine applications for pregnancy-related conditions, with increasing collaboration across immunology, gynecological oncology, and clinical pharmacology. His work on folate-mediated nanoparticle transport and indomethacin pharmacokinetics represents significant advances in understanding medication safety during pregnancy. Principal Investigator for "Nanobody Transplacental Transport" project (2020-2024) funded by Tectonic Therapeutic, Inc. Active research program with 69 total publications spanning 2004-2024 Significant citation impact with 2,697 total citations and h-index of 27 As laboratory director, Dr. Rytting leads a research team investigating novel delivery systems that balance maternal therapeutic needs with fetal protection, addressing one of medicine's most challenging pharmacological frontiers.

• Drug Delivery
• Nanomedicine
• Placental Transport
• +3 more

Daniela E Matei serves as Chief of Reproductive Science in Medicine and Diana, Princess of Wales Professor of Cancer Research at Northwestern University Feinberg School of Medicine. She holds dual professorships in Medicine (Hematology and Oncology) and Obstetrics and Gynecology (Gynecologic Oncology), with clinical practice at Northwestern Memorial Hospital. Her academic foundation includes: MD from University of Medicine, Bucharest (1992) Internship and Residency at Stony Brook University Medical Center (1996) Fellowship at University of California, Los Angeles (2002) Dr. Matei's research pioneers metabolic targeting in ovarian cancer, investigating ferroptosis induction through selenium deprivation and lipid oxidation manipulation. Her work bridges epigenetic regulation with immunotherapy enhancement, focusing on overcoming chemotherapy resistance through CRISPR-based metabolic vulnerability mapping and mRNA vaccine development. Recent 2025 publications demonstrate clinical-translational integration across prehabilitation protocols, combination immunotherapies, and mechanistic cancer metabolism studies, establishing ovarian cancer as the central disease model for therapeutic innovation. She leads active clinical trials including ACR-368-201 for platinum-resistant ovarian carcinoma and directs research within the Robert H. Lurie Comprehensive Cancer Center and Center for Reproductive Science. National leadership roles span NRG Oncology committees, ASCO Taxonomy Committee, and Department of Defense Ovarian Cancer Academy, driving collaborative advances in gynecologic oncology standards.

• Gynecologic Oncology
• Ovarian Cancer Research
• Cancer Metabolism
• +3 more

Michael Diamond is a Professor at the Medical College of Georgia, affiliated with the Department of Obstetrics and Gynecology and the Department of Physiology. He serves as Associate Dean for the Medical College of Georgia and AU Medical Associates, and holds the Charbonnier Endowed Chair in Reproductive Endocrinology. His research focuses on Reproductive Endocrinology and Infertility , integrating clinical and translational methodologies. Key areas include ovulation mechanisms, infertility treatments, postoperative adhesion epigenetics, and fertility outcomes in unexplained infertility cases. His recent publications span topics such as progesterone trigger protocols, uterine fibroid treatments, and genetic factors in infertility, reflecting interdisciplinary collaborations in obstetrics, genetics, and physiology. Notable awards include: Gold Medal Award (American Managed Care Pharmacy Nexus Conference, 2019) Star Award (American Society for Reproductive Medicine, 2013-2019) Georgia Bio Community Award (2016) Fertility and Sterility Investigator Achievement Award (2015) Service Milestone Award (2014)

• Reproductive Endocrinology
• Infertility
• Women's Reproductive Health
• +1 more

Mala Mahendroo, Ph.D., is a Professor in the Department of Obstetrics and Gynecology at UT Southwestern Medical Center and a member of the Cecil H. and Ida Green Center for Reproductive Biology Sciences. She leads an active research laboratory focused on understanding the biological and mechanical processes underlying cervical remodeling during pregnancy and preterm birth. Her research interests are centered on reproductive biology, molecular biology, and biochemistry, with a specific focus on cervical remodeling. Using techniques such as single-cell genomics, tissue biomechanics, imaging, and mouse models, her lab investigates hormone signaling, immunology, gene regulation, extracellular matrix dynamics, and epithelial barrier function. She collaborates with mechanical and biomedical engineers to develop translational imaging tools for assessing cervical changes. The analysis of her recent publications reveals a consistent focus on hyaluronan, collagen, glycosaminoglycans, immune cell dynamics, and mechanical properties of cervical tissue. Her work spans from basic molecular mechanisms to translational applications, particularly in predicting and preventing preterm birth. Imaging technologies like second harmonic generation are emerging as key tools in her research. Career Award in the Biomedical Sciences/Reproductive Biology from the Burroughs Welcome Fund National Institutes of Health Postdoctoral Fellowship Fellowship from The Lalor Foundation Career Award from the Burroughs Wellcome Fund Dr. Mahendroo has been continuously supported by major grants from the National Institutes of Health, March of Dimes, Burroughs Welcome Preterm Birth Initiatives, and The Hartwell Foundation. She mentors graduate students and postdoctoral fellows through the Cellular and Molecular Biology (CMB) and Biomedical Engineering (BME) programs. Her lab actively recruits motivated researchers interested in women’s health and reproductive biology. She leads the Mahendroo Laboratory at UT Southwestern, which integrates genomic, engineering, and cell biology approaches to study cervical function during pregnancy. The lab fosters interdisciplinary collaboration and innovation in reproductive health research.

• Reproductive Biology
• Molecular Biology
• Biochemistry
• +12 more

Yixiang Liao, PhD is an Associate Professor in the Department of Radiation Oncology at Rush Medical College, Rush University. As Director of the Medical Physics Residency Program, they focus on advancing radiation therapy techniques and training future medical physicists. Academic Rank: Associate Professor Institution: Rush University Department: Radiation Oncology Research spans three key areas: Brachytherapy (HDR techniques, applicator design), Medical Imaging (portal dosimetry, thermal imaging for skin reactions), and 3D Printing Applications (immobilization devices, vaginal HDR templates). Their work integrates Artificial Intelligence for segmentation modules and explores hypofractionation protocols in multidisciplinary debates. Key article trends include: Development of ergonomic brachytherapy applicators Advancements in 3D-printed patient-specific immobilization Validation of AI-driven segmentation tools Dosimetric robustness studies for radiation plans Interdisciplinary focus on optimizing cancer treatment protocols Scientific recognition includes the 2016 BEST IN PHYSICS (JOINT IMAGING-THERAPY) award for real-time tumor tracking innovations. Their career demonstrates sustained leadership in medical physics education and radiation therapy optimization.

• Medical Physics
• Radiation Oncology
• Brachytherapy
• +3 more

Dr. Benjamin P. Brown serves as the Mimi Pichey Assistant Professor of Obstetrics and Gynecology at Brown University's Warren Alpert Medical School, where he is Chief of the Section of Complex Family Planning. He practices as an attending physician in General Obstetrics and Gynecology at Women & Infants Hospital of Rhode Island, maintaining board certification in both obstetrics/gynecology and complex family planning. His clinical expertise spans high-acuity obstetrics, complex abortion/contraception care, and management of early pregnancy complications. Dr. Brown's research program critically examines reproductive and sexual health policy through bioethics and health services research lenses. He investigates the human impact of policy decisions on abortion access, contraception services, and healthcare equity, with particular focus on vulnerable populations. His interdisciplinary approach integrates clinical medicine, statistics, and ethical analysis to address systemic barriers in reproductive healthcare delivery. Analysis of his 2014-2023 publications reveals consistent methodological rigor in studying abortion policy effects, including multistate longitudinal analyses of provider distance impacts, restrictive legislation consequences, and federal policymaker affiliations. His work demonstrates evolving sophistication in linking policy variables to clinical outcomes while maintaining ethical frameworks for evaluating healthcare disparities. No scientific awards were specified in the available documentation. Dr. Brown actively mentors medical students and residents at the Warren Alpert Medical School, sharing expertise in clinical ethics and biostatistics. As Section Chief of Complex Family Planning, he leads clinical service development and research initiatives. While specific grant funding isn't detailed, his publication record indicates sustained research activity in reproductive health policy analysis through institutional and likely federal or foundation support.

• Reproductive Health
• Sexual Health
• Bioethics
• +1 more